Nexterone (captisol enabled amiodarone)
/ Ligand, Baxter Healthcare
- LARVOL DELTA
Home
Next
Prev
1 to 14
Of
14
Go to page
1
August 19, 2024
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
(clinicaltrials.gov)
- P2 | N=90 | Recruiting | Sponsor: OHSU Knight Cancer Institute | Trial completion date: Aug 2025 ➔ Aug 2026 | Trial primary completion date: Aug 2025 ➔ Aug 2026
Trial completion date • Trial primary completion date • Atrial Fibrillation • Cardiovascular • Esophageal Cancer • Gastrointestinal Cancer • Oncology
June 21, 2024
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
(clinicaltrials.gov)
- P2 | N=90 | Recruiting | Sponsor: OHSU Knight Cancer Institute | Not yet recruiting ➔ Recruiting
Enrollment open • Atrial Fibrillation • Cardiovascular • Esophageal Cancer • Gastrointestinal Cancer • Oncology
May 20, 2024
AAA: Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
(clinicaltrials.gov)
- P4 | N=42 | Recruiting | Sponsor: University of Calgary | Trial completion date: Dec 2026 ➔ Dec 2027 | Trial primary completion date: Dec 2025 ➔ Dec 2027
Trial completion date • Trial primary completion date • Atrial Fibrillation • Cardiovascular
April 05, 2024
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
(clinicaltrials.gov)
- P2 | N=90 | Not yet recruiting | Sponsor: OHSU Knight Cancer Institute | Initiation date: Jan 2024 ➔ May 2024
Trial initiation date • Atrial Fibrillation • Cardiovascular • Esophageal Cancer • Gastrointestinal Cancer • Oncology
October 04, 2023
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
(clinicaltrials.gov)
- P2 | N=90 | Not yet recruiting | Sponsor: OHSU Knight Cancer Institute
New P2 trial • Atrial Fibrillation • Cardiovascular • Esophageal Cancer • Gastrointestinal Cancer • Oncology
May 24, 2023
Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients
(clinicaltrials.gov)
- P3 | N=50 | Not yet recruiting | Sponsor: University of Calgary | Trial completion date: Sep 2024 ➔ Sep 2025 | Trial primary completion date: Jan 2024 ➔ Jan 2025
Surgery • Trial completion date • Trial primary completion date • Atrial Fibrillation • Cardiovascular
November 04, 2022
Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients
(clinicaltrials.gov)
- P3 | N=50 | Not yet recruiting | Sponsor: University of Calgary | Trial completion date: Sep 2023 ➔ Sep 2024 | Trial primary completion date: Sep 2023 ➔ Jan 2024
Trial completion date • Trial primary completion date • Atrial Fibrillation • Cardiovascular
February 24, 2022
AAA: Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
(clinicaltrials.gov)
- P4 | N=42 | Recruiting | Sponsor: University of Calgary | Not yet recruiting ➔ Recruiting
Enrollment open • Atrial Fibrillation • Cardiovascular
September 09, 2021
AAA: Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
(clinicaltrials.gov)
- P4; N=42; Not yet recruiting; Sponsor: University of Calgary; Initiation date: Jun 2021 ➔ Sep 2021
Trial initiation date • Atrial Fibrillation • Cardiovascular
June 21, 2021
Can Statins Cause Brain Fog?
(WebMD)
- "'One might need to ask the question: 'Is it really the drug?' Or is there something else going on here that would require formal evaluation with a neuropsychiatric specialist,' Rosenson says."
Media quote
October 20, 2020
AAA: Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
(clinicaltrials.gov)
- P4; N=42; Not yet recruiting; Sponsor: University of Calgary
New P4 trial • Atrial Fibrillation • Cardiovascular
March 27, 2018
"Read new CDC Blog: Familial Hypercholesterolemia is common 7 undertreated in the US #KnowFH #tier1 #pm101 @TheFHFoundation @nationallipid @NLAFoundation #NLASessions @NYUCVDPrevent @OHSUCardio @fhscglobal @ACCCardioEd @HeartNews @ACCinTouch @drpablocorral @gina_lundberg @Drlipid"
(@lipiddoc)
Clinical • Biosimilar • Cardiovascular • Dyslipidemia
March 14, 2020
"To be fair our hospital uses the nexterone product for first dose boluses so probably ubiquitous? :)"
(@CardiacRX)
Clinical
October 14, 2019
"GlaxoSmithKline @GSKUS has a number of oncology-related job openings and if you'll be at #ASHG19 in Houston this week- you can visit GSK Careers at booth 1049 #sciencejobs #oncology #genetics #genomics #PM101"
(@OncologyHiring)
1 to 14
Of
14
Go to page
1